Wide Ranks

LSTA

Lisata Therapeutics, Inc.

2.82

Top Statistics
Market Cap 23 M Forward PE -1.20 Revenue Growth 0.00 %
Current Ratio 9.42 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA 0.6300 Enterprise / Revenue Price To Sales Trailing12 Months
Profitability
Profit Margins 0.00 % Operating Margins
Balance Sheet
Total Cash 38 M Total Cash Per Share 4.60 Total Debt 223000
Total Debt To Equity 0.5870 Current Ratio 9.42 Book Value Per Share 5.91
All Measures
Short Ratio 179.00 % Message Board Id finmb_338272 Shares Short Prior Month 12406
Return On Equity -0.4403 City Basking Ridge Uuid 7737ddfa-5bcf-3d22-801a-3db97878a368
Previous Close 2.90 First Trade Date Epoch Utc 920 M Book Value 5.91
Beta 1.22 Total Debt 223000 Volume 6747
Price To Book 0.4773 Last Split Date 1 B Fifty Two Week Low 2.05
Total Cash Per Share 4.60 Shares Short Previous Month Date 1 B Target Median Price 14.00
Max Age 86400 Recommendation Mean 1.50 Sand P52 Week Change 0.3133
Target Mean Price 14.00 Net Income To Common -21071000 Short Percent Of Float 0.0025
Implied Shares Outstanding 8 M Trailing Peg Ratio None Last Fiscal Year End 1 B
Average Daily Volume10 Day 19150 Average Volume10days 19150 Total Cash 38 M
Next Fiscal Year End 1 B Held Percent Insiders 0.1913 Trailing PE 0.0000
Date Short Interest 1 B Most Recent Quarter 1 B Regular Market Previous Close 2.90
Target Low Price 13.00 Gmt Off Set Milliseconds -18000000 Fifty Day Average 2.92
Open 2.88 Free Cashflow -13248625 State NJ
Dividend Yield 0.00 % Return On Assets -0.2872 Time Zone Short Name EST
Trailing Eps -2.51 Day Low 2.82 Address1 110 Allen Road
Shares Outstanding 8 M Price Hint 4 Target High Price 15.00
Website https://www.lisata.com 52 Week Change 0.2877 Average Volume 13862
Forward Eps -2.52 Recommendation Key strong_buy Compensation As Of Epoch Date 1 B
Quick Ratio 858.50 % Last Split Factor 1:15 Regular Market Day High 2.88
Is_sp_500 False Profit Margins 0.00 % Debt To Equity 0.5870
Fifty Two Week High 3.83 Day High 2.88 Shares Short 17064
Regular Market Open 2.88 Industry Key biotechnology Earnings Growth 0.00 %
Revenue Growth 0.00 % Shares Percent Shares Out 0.0021 Operating Cashflow -19962000
Currency USD Time Zone Full Name America/New_York Market Cap 23 M
Is_nasdaq_100 False Zip 07920 Quote Type EQUITY
Industry Biotechnology Long Name Lisata Therapeutics, Inc. Regular Market Day Low 2.82
Held Percent Institutions 0.0907 Current Price 2.82 Address2 2nd Floor
Enterprise To Ebitda 0.6300 Financial Currency USD Current Ratio 9.42
Industry Disp Biotechnology Number Of Analyst Opinions 2 Country United States
Float Shares 6 M Two Hundred Day Average 3.05 Enterprise Value -15081316
Forward PE -1.20 Regular Market Volume 6747 Ebitda -23928000
Exchange NCM
Go to Yahoo Finance Go to Seeking Alpha 
Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other diseases.

Its product candidates include LSTA1, which is in Phase 2a and 2b clinical studies for the treatment of solid tumor, including metastatic pancreatic ductal adenocarcinoma (mPDAC), in combination with a range of anti-cancer regimens; XOWNA that is in Phase IIa clinical trial for the treatment of coronary microvascular dysfunction; and CD34+ cell therapy for the treatment of chronic kidney disease.

Lisata Therapeutics, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.